Does ENZALUTAMIDE Cause Flatulence? 258 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 258 reports of Flatulence have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.5% of all adverse event reports for ENZALUTAMIDE.
258
Reports of Flatulence with ENZALUTAMIDE
0.5%
of all ENZALUTAMIDE reports
23
Deaths
27
Hospitalizations
How Dangerous Is Flatulence From ENZALUTAMIDE?
Of the 258 reports, 23 (8.9%) resulted in death, 27 (10.5%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Flatulence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 258 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Flatulence?
ADALIMUMAB (1,651)
POLYETHYLENE GLYCOL 3350 (1,207)
VEDOLIZUMAB (949)
SEMAGLUTIDE (925)
TIRZEPATIDE (918)
LENALIDOMIDE (865)
NINTEDANIB (832)
DULAGLUTIDE (754)
OCTREOTIDE (699)
APREMILAST (617)
Which ENZALUTAMIDE Alternatives Have Lower Flatulence Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE